NEWS

    •  NEWS

  • Newsletter – September 2017, Click here
    • CiToxLAB North America acquires new facility in Laval / Montreal to meet the growing demand for laboratories services
    • The obese Göttingen Minipig model
    • Synthetic bone graft and bone substitute development programs: the rabbit Posterolateral Fusion (PLF) model
    • Gastrointestinal function: Motility and Motor Migrating Complex (MMC) evaluations across models
    • Positioning of mass spectrometry and immunoassays for large molecules bioanalysis
    • REACH compliance 2018 deadline
    • Conferences
  • Newsletter – March 2017, Click here
  • Newsletter – December 2016, Click here
  • Newsletter – July 2016, Click here
  • Newsletter – September 2015, Click here
  • Newsletter – March 2015, Click here
  • Newsletter – September 2014, Click here
  • Newsletter – July 2014, Click here
  • Newsletter – May 2014, Click here

 

    •  PRESS RELEASE

> NEW: CiToxLAB North America purchases new facility in Montreal, Canada

> CiToxLAB and KaLy-Cell join forces to offer in vitro and ex vivo testing for hepatotoxicity and metabolism

> CiToxLAB acquires AccelLAB, a Canadian CRO specialized in pre-clinical assessment of medical devices

> CiToxLAB appoints Alan Bartlett as Senior Director, Global Laboratory Operations

> CiToxLAB announces appointment of Philippe Ancian

> CiToxLAB announces appointment of John Kapeghian

> CiToxLAB Implements Provantis 9 and submit-SEND Solutions